ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...tion-How-should-we-decide-the-best-treatment

Date: 27 Sep 2014
Presenter: Jean-Louis Lefebvre
Resources: Presentation, Webcast
Topics: Head and Neck Cancers, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ry-efficacy-results-of-LUX-Head-Neck-1-a-pha

AimPatients with R/M HNSCC who progress after first-line platinum-based therapy have a dismal prognosis and no well-defined treatment. Afatinib, an irreversible ErbB family blocker, showed anti-tumor...

Date: 27 Sep 2014
Presenter: Jean-Pascal Machiels
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...ve-on-after-platinum-based-chemotherapy-PtCT

AimMEHD, a novel dual-action humanized IgG1 antibody that blocks ligand binding to EGFR and HER3, inhibits signaling from all ligand-dependent HER dimers, and can elicit antibody dependent cell mediated cytotoxicity.

Date: 27 Sep 2014
Presenter: Jérôme Fayette
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...CC-.-Final-analysis-of-AIO-trial-1108-CeFCiD

AimAnalysis of a trial investigating, whether TPFC would be feasible and superior to PFC in patients with RM-HNSCC without limiting comorbidities, based on the findings, that D in addition to PF in...

Date: 27 Sep 2014
Presenter: Maren Knoedler
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...-discussant-abstracts-LBA29_PR-986O-and-987O

Date: 27 Sep 2014
Presenter: Tanguy Seiwert
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...-2014/New-targets-in-squamous-cell-carcinoma

Body Abstract:Despite progress in the therapeutic management of patients with squamous cell carcinoma of the head and neck (SCCHN), the mortality rate of patients presenting with advanced disease remains high.

Date: 27 Sep 2014
Presenter: Jean-Pascal Machiels
Resources: Abstract, Presentation, Webcast
Topics: Head and Neck Cancers, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...ration-technology-for-next-generation-trials

Body Abstract:Cancer is assumed to be driven by a succession of genomic alterations. However, genomics has practically entered the clinic in oncology only with the emergence of molecularly targeted agents (MTAs).

Date: 27 Sep 2014
Presenter: Christophe Le Tourneau
Resources: Abstract
Topics: Head and Neck Cancers, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-2014/Immunotherapy-for-head-and-neck-cancer

Body Abstract:Head and neck squamous cell carcinoma is the sixth most common cancer in the western world. Little improvement in treatment has been made over the last few decades to increase the relatively low 5-year survival rate.

Date: 27 Sep 2014
Presenter: Erik Hooijberg
Resources: Abstract, Presentation, Webcast
Topics: Cancer Immunology and Immunotherapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...MO-2014/New-targets-in-salivary-gland-cancer

Body Abstract:Adenoid cystic carcinoma is a rare tumour arising primarily in the salivary gland but can arise in multiple body sites. It is characterized by an indolent clinical course with multiple...

Date: 27 Sep 2014
Presenter: Andrew Futreal
Resources: Abstract, Presentation, Webcast
Topics: Head and Neck Cancers, Pathology/Molecular Biology, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...MO-2014/Conclusion-and-clinical-perspectives

Date: 27 Sep 2014
Presenter: Sandrine Faivre
Resources: Presentation, Webcast
Topic: Head and Neck Cancers